190 related articles for article (PubMed ID: 10611136)
1. Single-dose methoxsalen effects on human cytochrome P-450 2A6 activity.
Kharasch ED; Hankins DC; Taraday JK
Drug Metab Dispos; 2000 Jan; 28(1):28-33. PubMed ID: 10611136
[TBL] [Abstract][Full Text] [Related]
2. Single-dose disulfiram does not inhibit CYP2A6 activity.
Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
[TBL] [Abstract][Full Text] [Related]
3. Human halothane metabolism, lipid peroxidation, and cytochromes P(450)2A6 and P(450)3A4.
Kharasch ED; Hankins DC; Fenstamaker K; Cox K
Eur J Clin Pharmacol; 2000; 55(11-12):853-9. PubMed ID: 10805064
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cytochrome P450 2A6 increases nicotine's oral bioavailability and decreases smoking.
Sellers EM; Kaplan HL; Tyndale RF
Clin Pharmacol Ther; 2000 Jul; 68(1):35-43. PubMed ID: 10945314
[TBL] [Abstract][Full Text] [Related]
5. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
[TBL] [Abstract][Full Text] [Related]
6. Metabolic interactions of methoxsalen and coumarin in humans and mice.
Mäenpää J; Juvonen R; Raunio H; Rautio A; Pelkonen O
Biochem Pharmacol; 1994 Oct; 48(7):1363-9. PubMed ID: 7945434
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
8. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
[TBL] [Abstract][Full Text] [Related]
9. Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1.
Kharasch ED; Hankins DC; Jubert C; Thummel KE; Taraday JK
Drug Metab Dispos; 1999 Jun; 27(6):717-23. PubMed ID: 10348802
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro.
Zhang W; Kilicarslan T; Tyndale RF; Sellers EM
Drug Metab Dispos; 2001 Jun; 29(6):897-902. PubMed ID: 11353760
[TBL] [Abstract][Full Text] [Related]
11. Determination of coumarin metabolism in Turkish population.
Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis A impairs the function of human hepatic CYP2A6 in vivo.
Pasanen M; Rannala Z; Tooming A; Sotaniemi EA; Pelkonen O; Rautio A
Toxicology; 1997 Dec; 123(3):177-84. PubMed ID: 9355936
[TBL] [Abstract][Full Text] [Related]
13. The effect of methoxsalen on nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in vivo.
Sellers EM; Ramamoorthy Y; Zeman MV; Djordjevic MV; Tyndale RF
Nicotine Tob Res; 2003 Dec; 5(6):891-9. PubMed ID: 14668073
[TBL] [Abstract][Full Text] [Related]
14. CYP2A6: a human coumarin 7-hydroxylase.
Pelkonen O; Rautio A; Raunio H; Pasanen M
Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
[TBL] [Abstract][Full Text] [Related]
15. Comparison of CYP2A6 catalytic activity on coumarin 7-hydroxylation in human and monkey liver microsomes.
Li Y; Li NY; Sellers EM
Eur J Drug Metab Pharmacokinet; 1997; 22(4):295-304. PubMed ID: 9512924
[TBL] [Abstract][Full Text] [Related]
16. Consumption of watercress fails to alter coumarin metabolism in humans.
Murphy SE; Johnson LM; Losey LM; Carmella SG; Hecht SS
Drug Metab Dispos; 2001 Jun; 29(6):786-8. PubMed ID: 11353744
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic polymorphism of CYP2A6 activity in a Chinese population.
Xu P; Huang SL; Zhu RH; Han XM; Zhou HH
Eur J Clin Pharmacol; 2002 Aug; 58(5):333-7. PubMed ID: 12185557
[TBL] [Abstract][Full Text] [Related]
18. Baculovirus-mediated expression and characterization of rat CYP2A3 and human CYP2a6: role in metabolic activation of nasal toxicants.
Liu C; Zhuo X; Gonzalez FJ; Ding X
Mol Pharmacol; 1996 Oct; 50(4):781-8. PubMed ID: 8863822
[TBL] [Abstract][Full Text] [Related]
19. Naringenin and interindividual variability in interaction of coumarin with grapefruit juice.
Bourian M; Runkel M; Krisp A; Tegtmeier M; Freudenstein J; Legrum W
Exp Toxicol Pathol; 1999 Jul; 51(4-5):289-93. PubMed ID: 10445384
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin and CYP2A6 activity in healthy subjects.
Asimus S; Hai TN; Van Huong N; Ashton M
Eur J Clin Pharmacol; 2008 Mar; 64(3):283-92. PubMed ID: 18064444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]